The Effect of Aspirin on Sickling and Oxygen Affinity of Erythrocytes
Author(s) -
Frank G. de Furia,
Anthony Cerami,
H. Franklin Bunn,
Yao-yan Lu,
C. Matthew Peterson
Publication year - 1973
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.70.12.3707
Subject(s) - deoxygenation , hemoglobin , aspirin , incubation , oxygen , chemistry , in vivo , sickle cell anemia , pharmacology , biochemistry , cell , in vitro , red blood cell , anemia , medicine , biology , catalysis , organic chemistry , microbiology and biotechnology
The recent suggestion that the administration of aspirin might be useful in the treatment of sickle-cell anemia has been further studied and found to be without basis. After incubation with aspirin, sickle-cell erythrocytes are not inhibited from sickling after deoxygenation. In addition, although aspirin does transfer the acetyl group to hemoglobin both in vitro and in vivo, in our experiments the reaction does not result in any alteration in the oxygen equilibrium of either intact erythrocytes or hemoglobin in solution. Furthermore, patients maintained on long-term aspirin administration also showed no shift in the oxygen affinity of their blood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom